Golimumab treatment elicited significantly better responses than placebo in week @ ASAS@ response -LSB- @ % ( @/@ ) vs @ % ( @/@ ) , respectively , P < @ -RSB- , week @ ASAS@ response ( @ % vs @ % , P < @ ) and mean improvements in BASFI ( -@ vs @ , P < @ ) and BASMI ( -@ vs -@ , P = @ ) scores at week @ .